297 related articles for article (PubMed ID: 16531280)
1. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
[TBL] [Abstract][Full Text] [Related]
2. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.
Murugeswari P; Shukla D; Rajendran A; Kim R; Namperumalsamy P; Muthukkaruppan V
Retina; 2008 Jun; 28(6):817-24. PubMed ID: 18536597
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of vitreous from diabetic macular edema.
Ouchi M; West K; Crabb JW; Kinoshita S; Kamei M
Exp Eye Res; 2005 Aug; 81(2):176-82. PubMed ID: 16080911
[TBL] [Abstract][Full Text] [Related]
5. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
6. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
8. [Protein composition of the vitreous body in proliferative diabetic retinopathy. An analysis with 2-D-electrophoresis].
Bresgen M; Baum U; Esser P; Wiedemann P; Heimann K
Ophthalmologe; 1994 Dec; 91(6):758-62. PubMed ID: 7849428
[TBL] [Abstract][Full Text] [Related]
9. Tyrosine phosphorylation of vitreous inflammatory and angiogenic peptides and proteins in diabetic retinopathy.
Reverter JL; Nadal J; Fernández-Novell JM; Ballester J; Ramió-Lluch L; Rivera MM; Elizalde J; Abengoechea S; Guinovart JJ; Rodríguez-Gil JE
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1378-82. PubMed ID: 18978347
[TBL] [Abstract][Full Text] [Related]
10. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
12. Proinflammatory cytokines and angiogenic and antiangiogenic factors in vitreous of patients with proliferative diabetic retinopathy and Eales' disease (ED).
Querques G; Delle Noci N
Retina; 2009 Jan; 29(1):121-3; author reply 123. PubMed ID: 18936719
[No Abstract] [Full Text] [Related]
13. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
[TBL] [Abstract][Full Text] [Related]
14. Identification of new pathogenic candidates for diabetic macular edema using fluorescence-based difference gel electrophoresis analysis.
Hernández C; García-Ramírez M; Colomé N; Corraliza L; García-Pascual L; Casado J; Canals F; Simó R
Diabetes Metab Res Rev; 2013 Sep; 29(6):499-506. PubMed ID: 23568601
[TBL] [Abstract][Full Text] [Related]
15. Catalogue of soluble proteins in the human vitreous humor: comparison between diabetic retinopathy and macular hole.
Nakanishi T; Koyama R; Ikeda T; Shimizu A
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Aug; 776(1):89-100. PubMed ID: 12127329
[TBL] [Abstract][Full Text] [Related]
16. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Hawlina M
Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
[TBL] [Abstract][Full Text] [Related]
17. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and leptin levels in diabetic retinopathy and retinal diseases.
Er H; Doğanay S; Ozerol E; Yürekli M
Ophthalmologica; 2005; 219(2):107-11. PubMed ID: 15802936
[TBL] [Abstract][Full Text] [Related]
19. Increased prostaglandin E2 (PGE2) levels in proliferative diabetic retinopathy, and correlation with VEGF and inflammatory cytokines.
Schoenberger SD; Kim SJ; Sheng J; Rezaei KA; Lalezary M; Cherney E
Invest Ophthalmol Vis Sci; 2012 Aug; 53(9):5906-11. PubMed ID: 22871833
[TBL] [Abstract][Full Text] [Related]
20. Identification and localization of major soluble vitreous proteins in human ocular tissue.
Wu CW; Sauter JL; Johnson PK; Chen CD; Olsen TW
Am J Ophthalmol; 2004 Apr; 137(4):655-61. PubMed ID: 15059704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]